NU Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,313 | 38,268 | 11,376 | 104,778 | 47,563 |
| Depreciation Amortization | 52,339 | 34,147 | 16,983 | 72,506 | 53,935 |
| Income taxes - deferred | -9,969 | 1,151 | -72 | -51,626 | 2,483 |
| Accounts receivable | -27,829 | -22,368 | -15,336 | -11,449 | -15,523 |
| Accounts payable and accrued liabilities | -4,667 | -4,195 | -4,495 | 9,263 | -1,224 |
| Other Working Capital | -101,143 | -99,439 | -64,080 | -135,961 | -119,437 |
| Other Operating Activity | 154,428 | 65,881 | 33,547 | 120,551 | 114,740 |
| Operating Cash Flow | $64,472 | $13,445 | $-22,077 | $108,062 | $82,537 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38,105 | -26,199 | -11,487 | -59,056 | -45,274 |
| Net Acquisitions | -77,275 | -77,275 | N/A | N/A | N/A |
| Purchase Of Investment | -16,883 | -16,883 | -8,195 | -13,955 | -13,955 |
| Sale Of Investment | 13,160 | 13,160 | 4,986 | 5,932 | 5,535 |
| Investing Cash Flow | $-119,103 | $-107,197 | $-14,696 | $-67,079 | $-53,694 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 110,000 | 110,000 | 20,000 | 460,000 | 460,000 |
| Debt Repayment | -12,382 | -6,546 | -3,412 | -434,419 | -411,401 |
| Common Stock Issued | 4,741 | 4,782 | 4,184 | 27,052 | 25,794 |
| Common Stock Repurchased | -13,011 | N/A | N/A | -70,045 | -60,038 |
| Dividend Paid | -58,353 | -38,867 | -19,392 | -77,015 | -57,988 |
| Other Financing Activity | 0 | 0 | 0 | -5,077 | -5,077 |
| Financing Cash Flow | $30,995 | $69,369 | $1,380 | $-99,504 | $-48,710 |
| Exchange Rate Effect | -7,775 | -4,788 | 609 | -16,347 | -25,590 |
| Beginning Cash Position | 264,725 | 264,725 | 264,725 | 339,593 | 339,593 |
| End Cash Position | 233,314 | 235,554 | 229,941 | 264,725 | 294,136 |
| Net Cash Flow | $-31,411 | $-29,171 | $-34,784 | $-74,868 | $-45,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,472 | 13,445 | -22,077 | 108,062 | 82,537 |
| Capital Expenditure | -38,105 | -26,199 | -11,487 | -59,056 | -45,274 |
| Free Cash Flow | 26,367 | -12,754 | -33,564 | 49,006 | 37,263 |